Puel J - Search Results

1

Assessment of a standardized reverse-transcriptase PCR assay for quantifying HIV-1 RNA in plasma and serum.

Izopet J, Poggi C, Dussaix E, Mansuy JM, Cubaynes L, Profizi N, Lafeuillade A, Marchou B, Massip P, Sayada C, Puel J. Izopet J, et al. Among authors: puel j. J Virol Methods. 1996 Jul;60(2):119-29. doi: 10.1016/0166-0934(96)02019-8. J Virol Methods. 1996. PMID: 8844617

2

Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay.

Izopet J, Tamalet C, Pasquier C, Sandres K, Marchou B, Massip P, Puel J. Izopet J, et al. Among authors: puel j. J Med Virol. 1998 Jan;54(1):54-9. doi: 10.1002/(sici)1096-9071(199801)54:1<54::aid-jmv8>3.0.co;2-o. J Med Virol. 1998. PMID: 9443109 Clinical Trial.

3

Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA.

Pasquier C, Sandres K, Salama G, Puel J, Izopet J. Pasquier C, et al. Among authors: puel j. J Virol Methods. 1999 Aug;81(1-2):123-9. doi: 10.1016/s0166-0934(99)00057-9. J Virol Methods. 1999. PMID: 10488770

4

Screening of blood from potential organ and cornea donors for viruses.

Miédougé M, Chatelut M, Mansuy JM, Rostaing L, Malecaze F, Sandres-Sauné K, Boudet F, Puel J, Abbal M, Izopet J. Miédougé M, et al. Among authors: puel j. J Med Virol. 2002 Apr;66(4):571-5. doi: 10.1002/jmv.2183. J Med Virol. 2002. PMID: 11857539

5

Virological and immunological effects of salvage therapy following treatment interruption and a shift in HIV-1 resistance genotype.

Izopet J, Souyris C, Sandres-Sauné K, Puissant B, Obadia M, Pasquier C, Puel J, Blancher A, Massip P. Izopet J, et al. Among authors: puel j. J Med Virol. 2002 Nov;68(3):305-10. doi: 10.1002/jmv.10204. J Med Virol. 2002. PMID: 12226815

6

Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression.

Izopet J, Cazabat M, Pasquier C, Sandres-Sauné K, Bonnet E, Marchou B, Massip P, Puel J. Izopet J, et al. Among authors: puel j. Virology. 2002 Oct 25;302(2):393-404. doi: 10.1006/viro.2002.1621. Virology. 2002. PMID: 12441083 Free article.

7

Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV.

Pasquier C, Bujan L, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, Massip P, Puel J, Izopet J. Pasquier C, et al. Among authors: puel j. J Med Virol. 2003 Mar;69(3):344-9. doi: 10.1002/jmv.10295. J Med Virol. 2003. PMID: 12526044

8

Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy.

Izopet J, Salama G, Pasquier C, Sandres K, Marchou B, Massip P, Puel J. Izopet J, et al. Among authors: puel j. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):478-83. doi: 10.1097/00042560-199812150-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9859961

9

Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations.

Izopet J, Sailler L, Sandres K, Pasquier C, Bonnet E, Aquilina C, Puel J, Massip P, Marchou B. Izopet J, et al. Among authors: puel j. J Med Virol. 1999 Feb;57(2):163-8. J Med Virol. 1999. PMID: 9892402 Clinical Trial.

10

Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.

Izopet J, Bicart-See A, Pasquier C, Sandres K, Bonnet E, Marchou B, Puel J, Massip P. Izopet J, et al. Among authors: puel j. J Med Virol. 1999 Dec;59(4):507-11. J Med Virol. 1999. PMID: 10534734 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

410 results

Search Page

Filters